Tags
Language
Tags
March 2024
Su Mo Tu We Th Fr Sa
25 26 27 28 29 1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31 1 2 3 4 5 6

Tuning the Brain: Principles and Practice of Neurosomatic Medicine 1st Edition

Posted By: alt_f4
Tuning the Brain: Principles and Practice of Neurosomatic Medicine 1st Edition

Tuning the Brain: Principles and Practice of Neurosomatic Medicine by Jay Goldstein
English | Jan. 23, 2004 | ISBN: 0789022451, 078902246X | 668 Pages | PDF | 9 MB

Discover effective, outcome-oriented ways to help CFS patients who have endured useless or inappropriate treatments!
From the author: “For many years I have viewed brain function as a system of electrochemical impulses continually flashing through the brain. These neural networks can often be modulated fairly simply by ’tuning’ them. The point I have been trying to make for many years is that this process may be pharmacologically regulated extremely rapidly in a manner which does not yet seem to be recognized by the medical profession.”

In this remarkable volume, Dr. Jay A. Goldstein clearly presents both the theoretical and the practical aspects of his revolutionary approach to treating CFS and other conditions that have often been termed psychosomatic. Dr. Goldstein (author of Chronic Fatigue Syndromes: The Limbic Hypothesis and Betrayal by the Brain: The Neurologic Basis of Chronic Fatigue Syndrome, Fibromyalgia Syndrome, and Related Neural Network Disorders) shows how he achieves results for patients with CFS and a variety of other syndromes in days, rather than months or years.

This well-referenced book answers questions, from the most basic to the most complex, including:

What is neurosomatic medicine?
How did Dr. Goldstein come to pioneer and practice this specialty?
What abnormalities in brain function produce neurosomatic disorders?
How can an understanding of these abnormalities help you provide effective treatment?
Why do these treatments sometimes work so rapidly?
What is receptor profiling, and how does it indicate the type of receptor dysregulation in an individual patient?